AltA-ZuZ Therapeutics
Pharmaceuticals - Ness Ziona, Center District, Israel
AltA-ZuZ Therapeutics Employees
AltA-ZuZ Therapeutics Details
AltA-ZuZ has developed a novel, first in class, orally bioavailable, small molecule for the treatment of autoimmune diseases. We have shown our molecule is a potent blocker of both B and T cell trafficking, far superior to other currently available therapies (Tysabri). Our molecule was shown to be safe in multiple administration routes (oral, IV, subcutaneous) and has shown impressive efficacy in mouse models of Inflamed Bowel Disease, Multiple Sclerosis, fatty liver disease, and collagen-induced arthritis
Employees:
1
HQ:
Location:
Ness Ziona, Center District, Israel
Revenue: